Brain Tumor Pathology

Papers
(The TQCC of Brain Tumor Pathology is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Intraspinal ASPSCR1::TFE3 rearranged tumor with nerve differentiation49
Preface for Brain Tumor Pathology vol.41 issue 215
Clinical, histopathological and molecular risk factors for recurrence of pilocytic astrocytomas: brainstem/spinal location, nestin expression and gain of 7q and 19 are associated with early tumor recu15
Correlation of MTAP immunohistochemical deficiency with CDKN2A homozygous deletion and clinicopathological features in pleomorphic xanthoastrocytoma14
Central nervous system ALK-negative anaplastic large cell lymphoma with IRF4/DUSP22 rearrangement14
Double-hit primary central nervous system lymphoma with histogenetically proven bone marrow infiltration: a case report and a review of the literature14
IDH wild-type lower-grade gliomas with glioblastoma molecular features: a systematic review and meta-analysis14
The oligodendroglial histological features are not independently predictive of patient prognosis in lower-grade gliomas14
Histopathological predictors of progression-free survival in atypical meningioma: a single-center retrospective cohort and meta-analysis11
Beyond the WHO 2021 classification of the tumors of the central nervous system: transitioning from the 5th edition to the next11
A clinicopathological analysis of supratentorial ependymoma, ZFTA fusion-positive: utility of immunohistochemical detection of CDKN2A alterations and characteristics of the immune microenvironment11
Targeting TGF-β signaling in glioblastoma: therapeutic implications and novel drug development strategies11
FISH analysis reveals CDKN2A and IFNA14 co-deletion is heterogeneous and is a prominent feature of glioblastoma10
Lynch syndrome-associated chordoma with high tumor mutational burden and significant response to immune checkpoint inhibitors9
Correction: Beyond the WHO 2021 classification of the tumors of the central nervous system: transitioning from the 5th edition to the next9
Comparative analyses of immune cells and alpha-smooth muscle actin-positive cells under the immunological microenvironment between with and without dense fibrosis in primary central nervous system lym8
Pediatric diffuse glioma with EP300::BCOR fusion manifesting as low-grade epilepsy-associated neuroepithelial tumor: a case presentation7
Tectal glioma: clinical, radiological, and pathological features, and the importance of molecular analysis6
Three-dimensional visualization of human brain tumors using the CUBIC technique6
The 2021 WHO classification of tumors, 5th edition, central nervous system tumors: the 10 basic principles6
Preface for Brain Tumor Pathology vol. 39 issue 26
Revisiting vimentin: a negative surrogate marker of molecularly defined oligodendroglioma in adult type diffuse glioma6
Spontaneous malignant transformation of trigeminal schwannoma: consideration of responsible gene alterations for tumorigenesis—a case report5
Triple sellar collision lesion: a unique case of pituitary adenoma, Rathke cleft cyst, and xanthogranuloma—case report and systematic review of the literature5
Revisiting the definition of glioma recurrence based on a phylogenetic investigation of primary and re-emerging tumor samples: a case report5
Timing of H3K27me3 loss in secondary anaplastic meningiomas5
Status of alternative angiogenic pathways in glioblastoma resected under and after bevacizumab treatment5
Easy-to-use machine learning system for the prediction of IDH mutation and 1p/19q codeletion using MRI images of adult-type diffuse gliomas5
Integrated analysis of MYC expression, 8q24.21 copy number, and recurrence patterns in astrocytoma, IDH-mutant5
Integrated analysis of multiple methods reveals characteristics of the immune microenvironment in medulloblastoma5
0.088950872421265